Professional Documents
Culture Documents
Process Analytical Technology
Process Analytical Technology
Process Analytical Technology
Seminar on
1
Vision :
To be center of professional excellence by contributing honestly to pharmacist molding
process.
Mission :
• Impart high quality education to graduates.
• Contribute to all sphere of professional activities.
• Uphold human value and ethics.
• Nature them into globally competent professional
2
Content
PAT has been defined as "a system for designing, analyzing, and controlling manufacturing through timely
measurements (i.e., during processing) of critical quality and performance attributes of raw and in-process
materials and processes, to ensure final product quality"
According to the United States Food and Drug Administration (FDA), Process Analytical Technology (PAT) is
defined as a mechanism for designing, analyzing, and controlling pharmaceutical manufacturing processes
through the measurement of Critical Process Parameters (CPP) that affect Critical Quality Attributes (CQA).
General Principle
4
Objectives of PAT
1. PAT enhances process understanding by identifying critical parameters
early.
2. It reduces waste and improves yield by preventing scrap and reprocessing.
3. Real-time release of batches is facilitated by implementing PAT in a three-
step process.
4. Design space exploration begins early to optimize unit operations.
5. Critical quality attributes & process parameters are identified in this
phase.
6. Understanding process intricacies is essential for effective PAT
implementation.
7. General FDA guidelines are needed to standardize PAT practices and
5
ensure regulatory compliance.
Generalized flow of PAT System:-
1. Selection of Process
3. Identification of CPP
4. Design Process
Temporary Process:-
Gaining process information & understanding the process
Permanent Process:-
Actual Process Monitoring and Control
7
There are 4 key elements play an important role in PAT Implementation
1. Building Science
2. Process monitoring and control
3. Validation of PAT System
4. Regulatory Strategy
1. Building Science:
8
3. Validation of PAT System:
4. Regulatory Strategy:
Documenting the implementation and performance of the PAT system in a comprehensive validation
report.
Engaging with regulatory agencies to discuss and gain approval for using PAT in manufacturing
processes.
Demonstrating compliance with regulatory requirements through thorough documentation and
adherence to industry guidelines.
9
Current Approaches in the PAT System
1. Spectroscopy:
Application: Employed for real-time analysis of pharmaceutical ingredients and formulations.
Techniques:
NIR spectroscopy for content uniformity testing,
IR spectroscopy for identification of raw materials,
Raman spectroscopy for in-line monitoring of crystallization processes.
2. Chromatography:
Usage: Integral for analyzing drug purity, stability, and impurity profiles.
Techniques:
HPLC for quantification of active pharmaceutical ingredients (APIs),
GC for volatile impurity analysis, and
LC-MS for identification of unknown compounds.
LIMITATIONS of Both Spectroscopy & Chromatography
4. Real-time Monitoring:
Significance: Crucial for ensuring batch-to-batch consistency and compliance with regulatory requirements.
Parameters:
Monitoring of temperature, pressure, pH, and API concentration during various manufacturing stages.
LIMITATIONS
1. Sensor reliability 2. Data Integrity
3. Deviations during a continuous process
11
5. Advanced Sensor Technologies:
Integration: Incorporation of advanced sensors for precise monitoring of manufacturing processes.
Examples:
Fiber optic probes for in-situ measurements,
Mass spectrometers for gas analysis, and
Electrochemical sensors for monitoring reaction kinetics.
LIMITATIONS
1. Cost of advanced techniques 2. Maintenance of that system
3. Performance reliability 4. Data interpretation
6. Modeling and Simulation:
Development: Creation of mechanistic models to simulate pharmaceutical processes.
Purpose: Predictive modeling for process optimization, scale-up, and risk assessment.
• The FDA's initiative on Process Analytical Technology (PAT) aims to modernize pharmaceutical
manufacturing processes by encouraging advanced analytical and monitoring techniques.
• FDA's initiative on PAT provides a framework and guidance for pharmaceutical manufacturers to adopt
innovative approaches to product development, manufacturing, and quality assurance, ultimately leading to
safer and more effective medicines for patients.
• PAT TOOLS: There are many tools available that enable process understanding for scientific, risk-managed
pharmaceutical product development manufacture & quality assurance.
16
1. Multivariate Tool for Design, Data Acquisition, and On-line measurement: The sample is diverted
Analysis: from the process, analyzed, and returned.
Example PAT Tool: On-line Raman
These tools allow for the analysis of complex datasets to Spectroscopy System
identify correlations between process variables and In-line Measurement: The sample is not
product quality attributes, aiding in the design of removed from the process stream.
experiments and optimization of processes. Example PAT Tool: In-line Near-Infrared
Example: Multivariate Data Analysis (MVDA) software (NIR) Analyze
packages like SIMCA, Umetrics MODDE, and CAMO
Unscrambler. Examples: Near-Infrared (NIR) Spectroscopy systems,
Raman Spectroscopy systems, or Mass Spectrometry
2. Process Analyzer: systems.
These tools enable automated control of manufacturing processes based on real-time data from process analyzers and
other sensors, ensuring that critical parameters remain within predefined limits.
Examples: Programmable Logic Controllers (PLCs), Distributed Control Systems (DCS), or Supervisory Control and
Data Acquisition (SCADA) systems.
These tools facilitate data management, documentation, and analysis, supporting continuous improvement initiatives
and knowledge management efforts within the organization. They help capture and share process knowledge, facilitate
decision-making, and support regulatory compliance efforts.
Examples: Electronic Laboratory Notebooks (ELNs), Manufacturing Execution Systems (MES), or Quality
Management Systems (QMS).
Each of these PAT tools plays a critical role in implementing the principles of PAT in pharmaceutical manufacturing,
enabling real-time monitoring, control, and optimization of processes to ensure product quality and consistency.
18
References
4. Guidance for Industry PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing,
and Quality Assurance [Internet]. 2004 Sep. Available from:
https://www.fda.gov/downloads/drugs/guidances/ucm070305.pdf5.
20